Neurotech USA   Report issue

For profit Phase 1
Founded: Lincoln RI United States (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2011
NCT01327911
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now